ESR1 and breast cancer: Among breast cancer subtypes, TNBC is a highly aggressive form characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounting for approximately 15-20% of all breast cancer cases (4).